Main Session
Sep
28
PQA 03 - PQA 03: Digital Health Innovation and Informatics, Patient Safety & Quality, and Radiation and Cancer Biology
2590 - Circulating Biomarkers Predictive of Response to Lu-PSMA-617 in Metastatic Castrate Resistant Prostate Cancer Patients
Presenter(s)
Daniel Rosen, MD, PhD - Brigham and Women's Hospital/Dana Farber Cancer Institute, Boston, MA